一个个性化的算法预测了急性性结肠炎中静脉输入皮质类固醇失效的风险
Anthony Croft1,2,3, Satomi Okano2, Gunter Hartel2
1Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Alimentary pharmacology & therapeutics
|August 7, 2024
概括
鉴定急性性结肠炎 (UC) 中高风险的皮质类固醇不响应患者至关重要. 使用机器学习开发的新风险评分准确预测非反应,有助于UC患者早期治疗决策.
科学领域:
- 胃肠病学 胃肠病学
- 临床信息学 临床信息学
- 预测分析是一种预测分析.
背景情况:
- 急性性结肠炎 (UC) 发作是患者疾病管理中的关键转折点.
- 预测早期的皮质类固醇不响应对于有效的UC治疗至关重要.
研究的目的:
- 开发一个个性化的算法来识别高风险的皮质类固醇不响应的患者.
- 在大规模的潜在急性UC患者数据库中使用机器学习技术.
主要方法:
- 分析了682例急性UC病例的数据.
- 使用弹性净模型进行变量选择和逻辑回归来构建风险评分.
- 在独立队列上验证的风险评分.
主要成果:
- 开发了两个风险评分算法:部分和全部 (包括内镜变量).
- 部分评分包括口服皮质类固醇的使用,肠道频率,专蛋白和CRP. 补充了梅奥内镜子底值和疾病程度的完整得分.
- 在验证队列中分别获得了0.76和0.78的部分和完整得分的AUC.
结论:
- 实用,个性化的风险评分 (ROR评分) 显示出在识别皮质类固醇不响应者方面表现强.
- 这些评分可以在内镜评估之前或之后使用,可能会改变急性UC治疗模式.
- 促进高风险UC患者的早期救援治疗或临床试验入学.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
109
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
109
Drugs for Treatment of Ulcerative Colitis in IBD
133
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
133
Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


